Relationships of Na+ and K+ concentrations to GRP, CGRP, and calcitonin immunoreactivities and Na+,K+-ATPase (NKA) inhibitory activity in human breast cyst fluid
暂无分享,去创建一个
V. D’Agati | V. P. Butler | Collin J. Weber | T. O'dorisio | M. Costanzo | B. Howe | Jennifer Morris | L. Ward | T. McDonald | D. Kim | V. Butler
[1] J. Zeuthen,et al. Gastrin releasing peptide GRP(14–27) in human breast cancer cells and in small cell lung cancer , 1991, Breast Cancer Research and Treatment.
[2] F.R.A.C.S. F.R.C.S. Professor Leslie E. Hughes D.S.,et al. Breast macrocysts , 2005, World Journal of Surgery.
[3] H. Leis. Gross breast cysts: significance of apocrine type, identification by cyst fluid analysis, and management , 1993 .
[4] A. Schally,et al. Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines. , 1992, Cancer research.
[5] M. Esmann,et al. The Na,K-ATPase , 1992, Journal of bioenergetics and biomembranes.
[6] M. Costantini,et al. Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast. , 1992, Cancer research.
[7] K. Patel,et al. Bombesin and glucocorticoids stimulate human breast cancer cells to produce endothelin, a paracrine mitogen for breast stromal cells. , 1992, Cancer research.
[8] Sterns Ee. The natural history of macroscopic cysts in the breast. , 1992 .
[9] E. Sterns. The natural history of macroscopic cysts in the breast. , 1992, Surgery, gynecology & obstetrics.
[10] V. D’Agati,et al. Vasoactive intestinal polypeptide-, neurotensin-, substance P-, gastrin-releasing peptide-, calcitonin-, calcitonin gene related peptide-, and somatostatin-like immunoreactivities in human parathyroid glands. , 1991, Surgery.
[11] A. Otaka,et al. Gastrin releasing peptide-like immunoreactive substance in rat mammary glands during pregnancy. , 1991, Biochemical and biophysical research communications.
[12] R. Davies,et al. Inhibition of the Na+,K(+)-ATPase pump during induction of experimental colon cancer. , 1991, Cancer biochemistry biophysics.
[13] M. Blaustein,et al. Identification and characterization of a ouabain-like compound from human plasma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[14] R. Murphy,et al. Bombesin stimulates proliferation of human breast cancer cells in culture. , 1991, British Journal of Cancer.
[15] K. V. Patel,et al. Mitogenic peptides in breast cyst fluid: Relationship with intracystic electrolyte ratios , 1990, International journal of cancer.
[16] J. Abita,et al. Characterization, in some human breast cancer cell lines, of gastrin‐releasing peptide‐like receptors which are absent in normal breast epithelial cells , 1990, International journal of cancer.
[17] L. Brinton. Relationship of Benign Breast Disease to Breast Cancer , 1990, Annals of the New York Academy of Sciences.
[18] R. Molina,et al. Biochemistry of Cyst Fluid in Fibrocystic Disease of the Breast , 1990, Annals of the New York Academy of Sciences.
[19] C. Gajdusek,et al. Identification of a unique biological tumor marker in human breast cyst fluid and breast cancer tissue. , 1990, American journal of surgery.
[20] C. Bodian,et al. Some Limitations on Studies about the Relation between Gross Cystic Disease and Risk of Subsequent Breast Cancer a , 1990, Annals of the New York Academy of Sciences.
[21] L. Dogliotti,et al. Biochemistry of Breast Cyst Fluid a , 1990, Annals of the New York Academy of Sciences.
[22] H. Bradlow,et al. Digoxinlike Materials in Human Breast Cyst Fluids , 1990, Annals of the New York Academy of Sciences.
[23] N. Standen,et al. Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels , 1990, Nature.
[24] K. Patel,et al. Activation of inositol phospholipid signaling and Ca2+ efflux in human breast cancer cells by bombesin. , 1990, Cancer research.
[25] A. Biggeri,et al. Risk of breast cancer subsequent to proven gross cystic disease. , 1990, European journal of cancer.
[26] D. Cremaschi,et al. Measurement with microelectrodes of intracellular Na+, K+, H+ and Cl- activities and of membrane potential in normal rat liver slices and during the 4-dimethylaminoazobenzene-induced rat hepatocarcinogenesis. , 1990, Cancer biochemistry biophysics.
[27] T. McDonald,et al. Gastrin-releasing peptide-, calcitonin gene-related peptide-, and calcitonin-like immunoreactivity in human breast cyst fluid and gastrin-releasing peptide-like immunoreactivity in human breast carcinoma cell lines. , 1989, Surgery.
[28] R. Greenblatt,et al. Gross cystic disease of the breast. , 1987, Maturitas.
[29] A. López-Rivas,et al. Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. II. Changes in Na+ and Ca2+ fluxes, Na+/K+ pump activity, and intracellular pH , 1986, The Journal of cell biology.
[30] H. Vorherr. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management. , 1986, American journal of obstetrics and gynecology.
[31] F. LaBella,et al. Endogenous ligands and modulators of the digitalis receptor: some candidates. , 1981, Pharmacology & therapeutics.
[32] A. Schwartz,et al. A kinetic comparison of cardiac glycoside interactions with Na+,K+-ATPases from skeletal and cardiac muscle and from kidney. , 1980, Archives of biochemistry and biophysics.
[33] J. H. Collins,et al. Large-scale purification of Na,K-ATPase and its protein subunits from lamb kidney medulla. , 1979, Preparative biochemistry.